PDB57 LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE 1 DIABETES PATIENTS TREATED WITH A BASAL-BOLUS REGIMEN IN GERMANY

Autor: Wiesner, T, Schädlich, PK, Dippel, FW, Koltermann, K, Hagenmeyer, EG
Zdroj: In Value in Health 2010 13(7):A294-A294
Databáze: ScienceDirect